Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

554 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Renin-angiotensin system inhibitor discontinuation in COVID-19 did not modify systemic ACE2 in a randomized controlled trial.
Rathkolb V, Traugott MT, Heinzel A, Poglitsch M, Aberle J, Eskandary F, Abrahamowicz A, Mueller M, Knollmueller P, Shoumariyeh T, Stuflesser J, Seeber I, Gibas G, Mayfurth H, Tinhof V, Schmoelz L, Zeitlinger M, Schoergenhofer C, Jilma B, Genser B, Hoepler W, Omid S, Karolyi M, Wenisch C, Oberbauer R, Zoufaly A, Hecking M, Reindl-Schwaighofer R. Rathkolb V, et al. Among authors: jilma b. iScience. 2023 Oct 5;26(11):108146. doi: 10.1016/j.isci.2023.108146. eCollection 2023 Nov 17. iScience. 2023. PMID: 37867935 Free PMC article.
The systemic renin-angiotensin system in COVID-19.
Reindl-Schwaighofer R, Hödlmoser S, Domenig O, Krenn K, Eskandary F, Krenn S, Schörgenhofer C, Rumpf B, Karolyi M, Traugott MT, Abrahamowicz A, Tinhof V, Mayfurth H, Rathkolb V, Mußnig S, Schmölz L, Ullrich R, Heinzel A, König F, Binder C, Bonderman D, Strassl R, Puchhammer-Stöckl E, Gorkiewicz G, Aberle JH, Jilma B, Wenisch C, Poglitsch M, Oberbauer R, Zoufaly A, Hecking M. Reindl-Schwaighofer R, et al. Among authors: jilma b. Sci Rep. 2022 Nov 22;12(1):20117. doi: 10.1038/s41598-022-24628-1. Sci Rep. 2022. PMID: 36418458 Free PMC article.
Immunoglobulin G production in COVID-19 - associations with age, outcome, viral persistence, inflammation and pro-thrombotic markers.
Pirabe A, Schrottmaier WC, Heber S, Schmuckenschlager A, Treiber S, Pereyra D, Santol J, Pawelka E, Traugott M, Schörgenhofer C, Seitz T, Karolyi M, Jilma B, Resch U, Zoufaly A, Assinger A. Pirabe A, et al. Among authors: jilma b. J Infect Public Health. 2023 Mar;16(3):384-392. doi: 10.1016/j.jiph.2023.01.016. Epub 2023 Jan 21. J Infect Public Health. 2023. PMID: 36702013 Free PMC article.
Disseminated Intravascular Coagulation in Anaphylaxis.
Gelbenegger G, Buchtele N, Schoergenhofer C, Grafeneder J, Schwameis M, Schellongowski P, Denk W, Jilma B. Gelbenegger G, et al. Among authors: jilma b. Semin Thromb Hemost. 2024 Jun;50(4):569-579. doi: 10.1055/s-0043-1776878. Epub 2023 Nov 29. Semin Thromb Hemost. 2024. PMID: 38029783 Review.
Drug-Drug Interactions in Patients with Acute Respiratory Distress Syndrome.
Bischof T, Schaller C, Buchtele N, Staudinger T, Ullrich R, Kraft F, Andersson ML, Jilma B, Schoergenhofer C. Bischof T, et al. Among authors: jilma b. Pharmaceutics. 2024 Feb 21;16(3):303. doi: 10.3390/pharmaceutics16030303. Pharmaceutics. 2024. PMID: 38543197 Free PMC article.
Anti-interleukin-6 Antibody Clazakizumab in Antibody-mediated Kidney Transplant Rejection: Effect on Donor-derived Cell-free DNA and C-X-C Motif Chemokine Ligand 10.
Mayer KA, Doberer K, Halloran PF, Budde K, Haindl S, Mühlbacher J, Eskandary F, Viard T, Casas S, Jilma B, Böhmig GA. Mayer KA, et al. Among authors: jilma b. Transplant Direct. 2022 Nov 10;8(12):e1406. doi: 10.1097/TXD.0000000000001406. eCollection 2022 Dec. Transplant Direct. 2022. PMID: 36382130 Free PMC article.
Endovascular thrombectomy with or without intravenous thrombolysis in large-vessel ischemic stroke: A non-inferiority meta-analysis of 6 randomised controlled trials.
Horvath LC, Bergmann F, Hosmann A, Greisenegger S, Kammerer K, Jilma B, Siller-Matula JM, Zeitlinger M, Gelbenegger G, Jorda A. Horvath LC, et al. Among authors: jilma b. Vascul Pharmacol. 2023 Jun;150:107177. doi: 10.1016/j.vph.2023.107177. Epub 2023 Apr 26. Vascul Pharmacol. 2023. PMID: 37116733 Free article.
Differential regulation of human thrombospondin-1 upon systemic desmopressin versus endotoxin challenge.
Scheuba A, Zagrapan B, Martelanz L, Eder V, Ibrahim N, Bleichert S, Knöbl V, Hayden H, von Kuenheim S, Münch K, Buchtele N, Schoergenhofer C, Kovacevic KD, Lackner E, Drucker C, Neumayer C, Jilma B, Brostjan C. Scheuba A, et al. Among authors: jilma b. Thromb Res. 2024 May;237:205-208. doi: 10.1016/j.thromres.2024.01.011. Epub 2024 Jan 15. Thromb Res. 2024. PMID: 38521738 Free article. No abstract available.
A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection.
Mayer KA, Schrezenmeier E, Diebold M, Halloran PF, Schatzl M, Schranz S, Haindl S, Kasbohm S, Kainz A, Eskandary F, Doberer K, Patel UD, Dudani JS, Regele H, Kozakowski N, Kläger J, Boxhammer R, Amann K, Puchhammer-Stöckl E, Vietzen H, Beck J, Schütz E, Akifova A, Firbas C, Gilbert HN, Osmanodja B, Halleck F, Jilma B, Budde K, Böhmig GA. Mayer KA, et al. Among authors: jilma b. N Engl J Med. 2024 May 25. doi: 10.1056/NEJMoa2400763. Online ahead of print. N Engl J Med. 2024. PMID: 38804514
554 results